Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world

References

• McIntosh ED, Reinert RR. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Rev Vaccines 2011; 10:109-29; PMID:21162625; https://doi.org/10.1586/erv.10.145
   PubMed Web of Science ®Google Scholar
• Varon E, Cohen R, Bechet S, Doit C, Levy C. Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children. Vaccine 2015; 33:6178-85; PMID:26476365; https://doi.org/10.1016/j.vaccine.2015.10.015
   PubMed Web of Science ®Google Scholar
• Fletcher MA, Schmitt HJ, Syrochkina M, Sylvester G. Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis 2014; 33:879-910; PMID:24563274; https://doi.org/10.1007/s10096-014-2062-6
   PubMed Web of Science ®Google Scholar
• Grabenstein JD, Musey LK. Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. Vaccine 2014; 32:2399-405; PMID:24637174; https://doi.org/10.1016/j.vaccine.2014.02.096
   PubMed Web of Science ®Google Scholar
• Garcia Gabarrot G, Lopez Vega M, Perez Giffoni G, Hernandez S, Cardinal P, Felix V, Gabastou JM, Camou T. Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country. PLoS One 2014; 9:e112337; PMID:25375647; https://doi.org/10.1371/journal.pone.0112337
   PubMed Web of Science ®Google Scholar
• Skoczynska A, Kuch A, Sadowy E, Wasko I, Markowska M, Ronkiewicz P, Matynia B, Bojarska A, Wasiak K, Golebiewska A, et al. Recent trends in epidemiology of invasive pneumococcal disease in Poland. Eur J Clin Microbiol Infect Dis 2015; 34:779-872; PMID:5475124; https://doi.org/10.1007/s10096-014-2283-8
   Web of Science ®Google Scholar
• Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Somekh E, Aviner S, Miron D, Dagan R. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance. Vaccine 2014; 32:3452-9; PMID:24690148; https://doi.org/10.1016/j.vaccine.2014.03.065
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Greenberg D, Hazan G, Givon-Lavi N, Gottesman G, Grisaru-Soen G, Dagan R. Differential impact of pneumococcal conjugate vaccines on bacteremic pneumonia versus other invasive pneumococcal disease. Pediatr Infect Dis J 2015; 34:409-16; PMID:25764098; https://doi.org/10.1097/INF.0000000000000604
   PubMed Web of Science ®Google Scholar
• von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von MC, Madhi SA, Zell ER, Verani JR, O'Brien KL, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med 2014; 371:1889-99; PMID:25386897; https://doi.org/10.1056/NEJMoa1401914
   PubMed Web of Science ®Google Scholar
• Ba F, Seck A, Ba M, Thiongane A, Cisse M, Seck K, Ndour M, Boisier P, Garin B. Identifying an appropriate PCV for use in Senegal, recent insights concerning Streptococcus pneumoniae NP carriage and IPD in Dakar. BMC Infect Dis 2014; 14:627; PMID:25471219; https://doi.org/10.1186/s12879-014-0627-8
   PubMed Web of Science ®Google Scholar
• Ndlangisa KM, du Plessis M, Wolter N, de GL, Klugman KP, von GA. Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines. PLoS One 2014; 9:e107666; PMID:25233455; https://doi.org/10.1371/journal.pone.0107666
   PubMed Web of Science ®Google Scholar
• Wei SH, Chiang CS, Chiu CH, Chou P, Lin TY. Pediatric invasive pneumococcal disease in taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2015; 34:e71-e77; PMID:25247584; https://doi.org/10.1097/INF.0000000000000565
   PubMed Web of Science ®Google Scholar
• Chiba N, Morozumi M, Shouji M, Wajima T, Iwata S, Ubukata K. Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan, 2010–2013. Emerg Infect Dis 2014; 20:1132-9; PMID:24960150; https://doi.org/10.3201/eid2007.131485
   PubMed Web of Science ®Google Scholar
• Cho EY, Lee H, Choi EH, Kim YJ, Eun BW, Cho YK, Kim YK, Jo DS, Lee HS, Lee J, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006–2010. Diagn Microbiol Infect Dis 2014; 78:481-6; PMID:24529940; https://doi.org/10.1016/j.diagmicrobio.2013.12.016
   PubMed Web of Science ®Google Scholar
• Lepoutre A, Varon E, Georges S, Dorleans F, Janoir C, Gutmann L, Levy-Bruhl D. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012. Vaccine 2015; 33:359-66; PMID:25448105; https://doi.org/10.1016/j.vaccine.2014.11.011
   PubMed Web of Science ®Google Scholar
• Aguiar SI, Brito MJ, Horacio AN, Lopes JP, Ramirez M, Melo-Cristino J. Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012. Euro Surveill 2014; 19:20750.
   PubMedGoogle Scholar
• Del Amo E, Brotons P, Monsonis M, Trivino M, Inigo M, Selva L, Sa-Leao R, Munoz-Almagro C. High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines. Clin Microbiol Infect 2014; 20:684-9; PMID:24467648; https://doi.org/10.1111/1469-0691.12422
   PubMed Web of Science ®Google Scholar
• Navarro-Torne A, Dias JG, Hruba F, Lopalco PL, Pastore-Celentano L, Gauci AJ. Risk factors for death from invasive pneumococcal disease, Europe, 2010. Emerg Infect Dis 2015; 21:417-25; https://doi.org/10.3201/eid2103.140634
   PubMed Web of Science ®Google Scholar
• Navarro Torne A, Dias JG, Quinten C, Hruba F, Busana MC, Lopalco PL, Gauci AJ, Pastore-Celentano L. European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. Vaccine 2014; 32:3644-50; PMID:24795228; https://doi.org/10.1016/j.vaccine.2014.04.066
   PubMed Web of Science ®Google Scholar
• Del Amo E, Selva L, de Sevilla MF, Ciruela P, Peris N, Hernandez S, Salleras L, Garcia-Garcia JJ, Dominguez A, and Muñoz-Almagro C. Serotype distribution of S.pneumoniae in children with invasive disease and in healthynasopharyngeal carriers: usefulness of direct capsular typing by molecular methods. Poster presented at 24th ECCMID; May 10–13. Barcelona, Spain: 2014.
   Google Scholar
• Echaniz-Aviles G, Soto-Nogueron A, Miranda-Novales G, Carnalla-Barajas MN, Velazquez-Meza ME, Solorzano-Santos F. Streptococcus pneumoniae serotypes identified in Mexican children with invasive disease before and after the introduction of PCV7 (1993–2012). Arch Med Res 2015; 46:149-53; PMID:25743930; https://doi.org/10.1016/j.arcmed.2015.02.004
   PubMed Web of Science ®Google Scholar
• Abate HJ, Falaschi A, Balbi L, Garcia B. Nineteen-years of pneumococcal invasive disease surveillance in a children's hospital in Mendoza, Argentina. Arch Argent Pediatr 2014; 112:352-7; PMID:24955907
   PubMedGoogle Scholar
• Parra EL, Ramos V, Sanabria O, Moreno J. Serotype and genotype distribution among invasive Streptococcus pneumoniae isolates in Colombia, 2005–2010. PLoS One 2014; 9:e84993; PMID:24416330; https://doi.org/10.1371/journal.pone.0084993
   PubMed Web of Science ®Google Scholar
• Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis 2015; 15:301-9; PMID:25656600; https://doi.org/10.1016/S1473-3099(14)71081-3
   PubMed Web of Science ®Google Scholar
• De Wals P, Lefebvre B, Markowski F, Deceuninck G, Defay F, Douville-Fradet M, Landry M. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine 2014; 32:1501-6; PMID:24486346; https://doi.org/10.1016/j.vaccine.2013.11.028
   PubMed Web of Science ®Google Scholar
• Sader HS, Mendes RE, Farrell DJ, Flamm RK, Jones RN. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011–2012). Pediatr Infect Dis J 2014; 33:837-42; PMID:25222304; https://doi.org/10.1097/INF.0000000000000307
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis 2014; 59:1724-32; PMID:25159581; https://doi.org/10.1093/cid/ciu683
   PubMed Web of Science ®Google Scholar
• Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA. Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-Nonsusceptible Streptococcus pneumoniae. J Infect Dis 2015; 211:1144-53; PMID:25355940; https://doi.org/10.1093/infdis/jiu576
   PubMed Web of Science ®Google Scholar
• Nzenze SA, von GA, Shiri T, van NN, de GL, Violari A, Nunes MC, Madhi SA. Temporal changes in pneumococcal colonization in HIV-infected and HIV-uninfected mother-child pairs following transitioning from 7-valent to 13-valent pneumococcal conjugate vaccine, Soweto, South Africa. J Infect Dis 2015; 212:1082-92; PMID:25784729; https://doi.org/10.1093/infdis/jiv167
   PubMed Web of Science ®Google Scholar
• Hammitt LL, Akech DO, Morpeth SC, Karani A, Kihuha N, Nyongesa S, Bwanaali T, Mumbo E, Kamau T, Sharif SK, et al. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health 2014; 2:e397-e405; PMID:25103393; https://doi.org/10.1016/S2214-109X(14)70224-4
   PubMed Web of Science ®Google Scholar
• Daana M, Rahav G, Hamdan A, Thalji A, Jaar F, Abdeen Z, Jaber H, Goral A, Huppert A, Raz M, et al. Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR). Vaccine 2015; 33:1021-6; PMID:25593104; https://doi.org/10.1016/j.vaccine.2015.01.003
   PubMed Web of Science ®Google Scholar
• Nunes MC, Jones SA, Groome MJ, Kuwanda L, van NN, von GA, de GL, Adrian PV, Madhi SA. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age. Vaccine 2015; 33:628-34; PMID:25541213; https://doi.org/10.1016/j.vaccine.2014.12.023
   PubMed Web of Science ®Google Scholar
• Geng Q, Zhang T, Ding Y, Tao Y, Lin Y, Wang Y, Black S, Zhao G. Molecular characterization and antimicrobial susceptibility of Streptococcus pneumoniae isolated from children hospitalized with respiratory infections in Suzhou, China. PLoS One 2014; 9:e93752; PMID:24710108; https://doi.org/10.1371/journal.pone.0093752
   PubMed Web of Science ®Google Scholar
• Hoskins A, Collins D, Senasinghe K, Bowman J, Stemberger NA, Jones J, Riley TV, Hare K, Smith-Vaughan H, Leach AJ, Lehmann D. Pneumococcal carriage rates remain high in Western Australian aboriginal people: 12 years and two vaccines later. Poster presented at Infectious Diseases Society of America Meeting; 2014 Oct 8–12. Philadelphia: 2014.
   Google Scholar
• Ho PL, Chiu SS, Law PY, Chan EL, Lai EL, Chow KH. Increase in the nasopharyngeal carriage of non-vaccine serogroup 15 Streptococcus pneumoniae after introduction of children pneumococcal conjugate vaccination in Hong Kong. Diagn Microbiol Infect Dis 2015; 81:145-8; PMID:25483278; https://doi.org/10.1016/j.diagmicrobio.2014.11.006
   PubMed Web of Science ®Google Scholar
• Kandasamy R, Gurung M, Thapa A, Ndimah S, Adhikari N, Murdoch DR, Kelly DF, Waldron DE, Gould KA, Thorson S, et al. Multi-serotype pneumococcal nasopharyngeal carriage prevalence in vaccine naive Nepalese children, assessed using molecular serotyping. PLoS One 2015; 10:e0114286; PMID:25643355; https://doi.org/10.1371/journal.pone.0114286
   PubMed Web of Science ®Google Scholar
• Khoshdel A, Rastabi RI, Doosti A, Askari S, Hafizi M. Prevalence of heptavalent vaccine-related pneumococcal serotypes in nasopharyngeal carrier in children under five years old in Shahrekord, Iran by Multiplex-PCR during. J Clin Diagn Res 2014; 8:C01-C04.
   Google Scholar
• Farida H, Severin JA, Gasem MH, Keuter M, Wahyono H, Van Den Broek P, Hermans PWM, Verbrugh HA. Nasopharyngeal carriage of Streptococcus pneumonia in pneumonia-prone age groups in Semarang, Java Island, Indonesia. PLoS One 2014; 9:e87431; PMID:24498104; https://doi.org/10.1371/journal.pone.0087431
   PubMed Web of Science ®Google Scholar
• Hanieh S, Hamaluba M, Kelly DF, Metz JA, Wyres KL, Fisher R, Pradhan R, Shakya D, Shrestha L, Shrestha A, et al. Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementation. PLoS One 2014; 9:e98739; PMID:24905574; https://doi.org/10.1371/journal.pone.0098739
   PubMed Web of Science ®Google Scholar
• Luminos M, Dorobat O, Jugulete G, Popescu GA, Florea D, Draganescu A, Cercel AS, Rafila A. Nasopharyngeal carriage of Streptococcus pneumoniae in Romanian children before the introduction of the pneumococcal conjugated vaccination into the national immunization programme: a national, multi-centre, cross-sectional observational study. Int J Infect Dis 2014; 29:169-73; PMID:25461243; https://doi.org/10.1016/j.ijid.2014.08.020
   PubMed Web of Science ®Google Scholar
• Mayanskiy N, Alyabieva N, Lazareva A, Ponomarenko O, Katosova L, Ivanenko A, Lazareva M, Kulichenko T, and Namazova-Baranova L. Noninvasive pneumococcal serotypes in hospitalized children in Moscow (Russia). Presented at 24th ECCMID; May 10–13. Barcelona, Spain: 2014.
   Google Scholar
• Dunais B, Bruno P, Touboul P, Degand N, Sakarovitch C, Fontas E, Haas H, Girard-Pipau F, Ruimy R, Pradier C. Impact of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus Pneumoniae among children attending group daycare in Southeastern France. Pediatr Infect Dis J 2015; 34:286-8; PMID:25742079; https://doi.org/10.1097/INF.0000000000000559
   PubMed Web of Science ®Google Scholar
• Mameli C, Fabiano V, Daprai L, Bedogni G, Faccini M, Garlaschi ML, Penagini F, Dilillo D, Torresani E, Gramegna M, et al. A longitudinal study of Streptococcus Pneumoniae carriage in healthy children in the 13-valent Pneumococcal Conjugate vaccine era. Hum Vaccin Immunother 2015; 11:811-7; PMID:25751237; https://doi.org/10.1080/21645515.2015.1010945
   PubMed Web of Science ®Google Scholar
• van der Linden M, Imohl M, Busse A, Rose M, Adam D. Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. Eur J Pediatr 2015; 174:355-64; PMID:25169065; https://doi.org/10.1007/s00431-014-2409-0
   PubMed Web of Science ®Google Scholar
• Grivea IN, Priftis KN, Giotas A, Kotzia D, Tsantouli AG, Douros K, Michoula AN, Syrogiannopoulos GA. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece. Vaccine 2014; 32:6513-20; PMID:25252194; https://doi.org/10.1016/j.vaccine.2014.09.016
   PubMed Web of Science ®Google Scholar
• Pasinato A, Indolfi G, Marchisio P, Valleriani C, Cortimiglia M, Spanevello V, Chiamenti G, Buzzetti R, Resti M, Azzari C. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR. Vaccine 2014; 32:1375-81; PMID:24486364; https://doi.org/10.1016/j.vaccine.2014.01.023
   PubMed Web of Science ®Google Scholar
• Gladstone RA, Jefferies JM, Tocheva AS, Beard KR, Garley D, Chong WW, Bentley SD, Faust SN, Clarke SC. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Vaccine 2015; 33:2015-21; PMID:25776920; https://doi.org/10.1016/j.vaccine.2015.03.012
   Web of Science ®Google Scholar
• Alfayate-Miguelez S, Ruiz-Gomez J, Fenoll-Comes A, Sanchez-Solis-De QM, Iofrio-De AA, Casquet-Barcelo A, Sanz-Mateo G, Espejo-Garcia P, Lorente-Garcia S, Sanchez-Andrada RM, et al. [Epidemiological study of nasopharyngeal carriers of Streptococcus pneumoniae in children in Murcia region]. Enferm Infecc Microbiol Clin 2014; 32:434-40; PMID:25034854; https://doi.org/10.1016/j.eimc.2013.07.013
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Griffin MR, Edwards KM, Williams JV, Gil AI, Verastegui H, Hartinger SM, Vidal JE, Klugman KP, Lanata CF. The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children. Clin Infect Dis 2014; 58:1369-76; PMID:24621951; https://doi.org/10.1093/cid/ciu148
   PubMed Web of Science ®Google Scholar
• Martin JM, Hoberman A, Paradise JL, Barbadora KA, Shaikh N, Bhatnagar S, Shope T, Block SL, Haralam MA, Kurs-Lasky M, et al. Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J 2014; 33:e286-e290; PMID:24911895; https://doi.org/10.1097/INF.0000000000000445
   PubMed Web of Science ®Google Scholar
• Ricketson LJ, Wood ML, Vanderkooi OG, MacDonald JC, Martin IE, Demczuk WH, Kellner JD. Trends in asymptomatic nasopharyngeal colonization with streptococcus pneumoniae after introduction of the 13-valent pneumococcal conjugate vaccine in Calgary, Canada. Pediatr Infect Dis J 2014; 33:724-30; PMID:24463806; https://doi.org/10.1097/INF.0000000000000267
   PubMed Web of Science ®Google Scholar
• Gounder PP, Bruce MG, Bruden DJ, Singleton RJ, Rudolph K, Hurlburt DA, Hennessy TW, Wenger J. Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae–Alaska, 2008–2012. J Infect Dis 2014; 209:1251-8; PMID:24273178; https://doi.org/10.1093/infdis/jit642
   PubMed Web of Science ®Google Scholar
• Loughlin AM, Hsu K, Silverio AL, Marchant CD, Pelton SI. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children. Pediatr Infect Dis J 2014; 33:504-10; PMID:24670957; https://doi.org/10.1097/INF.0000000000000279
   PubMed Web of Science ®Google Scholar
• Keck JW, Wenger JD, Bruden DL, Rudolph KM, Hurlburt DA, Hennessy TW, Bruce MG. PCV7-induced changes in pneumococcal carriage and invasive disease burden in Alaskan children. Vaccine 2014; 32:6478-84; PMID:25269095; https://doi.org/10.1016/j.vaccine.2014.09.037
   PubMed Web of Science ®Google Scholar
• Harboe ZB, Dalby T, Weinberger DM, Benfield T, Molbak K, Slotved HC, Suppli CH, Konradsen HB, Valentiner-Branth P. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis 2014; 59:1066-73; PMID:25034421; https://doi.org/10.1093/cid/ciu524
   PubMed Web of Science ®Google Scholar
• Guevara M, Ezpeleta C, Gil-Setas A, Torroba L, Beristain X, Aguinaga A, Garcia-Irure JJ, Navascues A, Garcia-Cenoz M, Castilla J, et al. Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001–2013. Vaccine 2014; 32:2553-62; PMID:24674661; https://doi.org/10.1016/j.vaccine.2014.03.054
   PubMed Web of Science ®Google Scholar
• Verhaegen J, Flamaing J, De Backer W, Delaere B, Van HK, Surmont F, Van LY, Van DP, Peetermans W. Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009–2011. Euro Surveill 2014; 19:14-22; PMID:25138972; https://doi.org/10.2807/1560-7917.ES2014.19.31.20869
   PubMedGoogle Scholar
• Ochoa-Gondar O, Gomez-Bertomeu F, Vila-Corcoles A, Raga X, Aguirre C, Utrera J, de DC, Guzman JA, Figuerola E. Prevalence of serotypes causing invasive pneumococcal disease in the region of Tarragona, Spain, 2006–2009: vaccine-serotype coverage for the distinct antipneumococcal vaccine formulations. Rev Esp Quimioter 2015; 28:29-35; PMID:25690142
   PubMed Web of Science ®Google Scholar
• Wortham JM, Zell ER, Pondo T, Harrison LH, Schaffner W, Lynfield R, Thomas A, Reingold A, Bennett NM, Petit S, et al. Racial disparities in invasive Streptococcus pneumoniae infections, 1998–2009. Clin Infect Dis 2014; 58:1250-7; PMID:24585565; https://doi.org/10.1093/cid/ciu108
   PubMed Web of Science ®Google Scholar
• Kim MJ, Kee SY, Baik SH, Choi YH, Bae I, Kim SY, Kim YK, Hur JA, Jo YM, and Song JY. Current epidemiology and burden of pneumococcal disease in elderly population in the Republic of Korea: A prospective, multicenter, observational study. Poster presented at 24th ECCMID; May 10–13. Barcelona, Spain: 2014.
   Google Scholar
• Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States. Antimicrob Agents Chemother 2014; 58:6484-9; PMID:25136018; https://doi.org/10.1128/AAC.03344-14
   PubMed Web of Science ®Google Scholar
• Domenech A, Ardanuy C, Tercero A, Garcia-Somoza D, Santos S, Linares J. Dynamics of the pneumococcal population causing acute exacerbations in COPD patients in a Barcelona hospital (2009–12): comparison with 2001–04 and 2005–08 periods. J Antimicrob Chemother 2014; 69:932-9; PMID:24324221; https://doi.org/10.1093/jac/dkt476
   PubMed Web of Science ®Google Scholar
• Kim L, Taylor TH, Jr., Pondo T, Farley MM, Schaffner W, Reingold A, Thomas A, Harrison LH, Lynfield R, Bennett NM, Petit S, Miller L, Nichols M, McGee L, Beall B. Impact of 13-valent Pneumococcal Conjugate vaccine on invasive pneumococcal disease in the United States. Presented at ID Week; October 10. Philadelphia, PA: 2014.
   Google Scholar
• Van Mens SP, van Deursen AM, Meijvis SC, Vlaminckx BJ, Sanders EA, De Melker HE, Schouls LM, van der Ende A, De Greeff SC, Rijkers GT. Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands. Epidemiol Infect 2014; 142:1996-9; PMID:24229845; https://doi.org/10.1017/S0950268813002860
   PubMed Web of Science ®Google Scholar
• Weil-Olivier C, Gaillat J. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults? Vaccine 2014; 32:2022-6; PMID:24565755; https://doi.org/10.1016/j.vaccine.2014.02.008
   PubMed Web of Science ®Google Scholar
• Tin Tin Htar M, Christopoulou D, Schmitt HJ. Pneumococcal serotype evolution in Western Europe. BMC Infect Dis 2015; 15:419; PMID:26468008; https://doi.org/10.1186/s12879-015-1147-x
   PubMed Web of Science ®Google Scholar